Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 May 1;80(3-4):556–562. doi: 10.1038/sj.bjc.6690391

Chromosome band 16q24 is frequently deleted in human gastric cancer

Y Mori 1,3, M Matsunaga 1, T Abe 1,2, S Fukushige 1, K Miura 2, M Sunamura 2, K Shiiba 2, M Sato 1,4, T Nukiwa 3, A Horii 1
PMCID: PMC2362314  PMID: 10408866

Abstract

We have analysed the loss of heterozygosity (LOH) on chromosome bands 16q22–q24 in 24 primary gastric cancer tissues and found three regions of frequent allelic loss (16q22, 16q24.1–q24.3 and 16q24.3). The region for the most frequent allelic loss (63%) was in 16q24.1–q24.3. LOH of this region had no relationship with histological subtype, but a significant association between LOH and microscopic lymphangial invasion was observed. Although not significant, vascular and gastric wall invasions are also associated with LOH. The region includes the locus for the H-cadherin gene. Therefore we examined the genetic and epigenetic alterations of this gene. Markedly reduced expression was observed in gastric cancer cell lines compared with that of normal gastric mucosa. However, no mutation was found in this gene in any of the gastric cancer tissues or the gastric cancer cell lines. Furthermore, we analysed the methylation status of the 5'-flanking region of the gene, but no significant association was found. We suggest that some other tumour suppresser gene(s) in 16q24.1–q24.3 may be responsible for gastric carcinogenesis. © 1999 Cancer Research Campaign

Keywords: gastric cancer, LOH, 16q, H-cadherin, microsatellite

Full Text

The Full Text of this article is available as a PDF (175.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baffa R., Negrini M., Mandes B., Rugge M., Ranzani G. N., Hirohashi S., Croce C. M. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 1996 Jan 15;56(2):268–272. [PubMed] [Google Scholar]
  2. Barletta C., Scillato F., Sega F. M., Mannella E. Genetic alteration in gastrointestinal cancer. A molecular and cytogenetic study. Anticancer Res. 1993 Nov-Dec;13(6A):2325–2329. [PubMed] [Google Scholar]
  3. Blaeker H., Rasheed B. K., McLendon R. E., Friedman H. S., Batra S. K., Fuchs H. E., Bigner S. H. Microsatellite analysis of childhood brain tumors. Genes Chromosomes Cancer. 1996 Jan;15(1):54–63. doi: 10.1002/(SICI)1098-2264(199601)15:1<54::AID-GCC8>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
  4. Deng G. R., Lu Y. Y., Chen S. M., Miao J., Lu G. R., Li H., Cai H., Xu X. L., E Z., Liu P. N. Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. Cancer Res. 1987 Jun 15;47(12):3195–3198. [PubMed] [Google Scholar]
  5. Doggett N. A., Goodwin L. A., Tesmer J. G., Meincke L. J., Bruce D. C., Clark L. M., Altherr M. R., Ford A. A., Chi H. C., Marrone B. L. An integrated physical map of human chromosome 16. Nature. 1995 Sep 28;377(6547 Suppl):335–365. doi: 10.1038/377335a0. [DOI] [PubMed] [Google Scholar]
  6. Dorion-Bonnet F., Mautalen S., Hostein I., Longy M. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer. 1995 Nov;14(3):171–181. doi: 10.1002/gcc.2870140304. [DOI] [PubMed] [Google Scholar]
  7. Elo J. P., Härkönen P., Kyllönen A. P., Lukkarinen O., Poutanen M., Vihko R., Vihko P. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res. 1997 Aug 15;57(16):3356–3359. [PubMed] [Google Scholar]
  8. Ezaki T., Yanagisawa A., Ohta K., Aiso S., Watanabe M., Hibi T., Kato Y., Nakajima T., Ariyama T., Inazawa J. Deletion mapping on chromosome 1p in well-differentiated gastric cancer. Br J Cancer. 1996 Feb;73(4):424–428. doi: 10.1038/bjc.1996.76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fukushige S., Waldman F. M., Kimura M., Abe T., Furukawa T., Sunamura M., Kobari M., Horii A. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer. 1997 Jul;19(3):161–169. doi: 10.1002/(sici)1098-2264(199707)19:3<161::aid-gcc5>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  10. Gleeson C. M., Sloan J. M., McGuigan J. A., Ritchie A. J., Weber J. L., Russell S. E. Allelotype analysis of adenocarcinoma of the gastric cardia. Br J Cancer. 1997;76(11):1455–1465. doi: 10.1038/bjc.1997.578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Greig G. M., England S. B., Bedford H. M., Willard H. F. Chromosome-specific alpha satellite DNA from the centromere of human chromosome 16. Am J Hum Genet. 1989 Dec;45(6):862–872. [PMC free article] [PubMed] [Google Scholar]
  12. Guilford P., Hopkins J., Harraway J., McLeod M., McLeod N., Harawira P., Taite H., Scoular R., Miller A., Reeve A. E. E-cadherin germline mutations in familial gastric cancer. Nature. 1998 Mar 26;392(6674):402–405. doi: 10.1038/32918. [DOI] [PubMed] [Google Scholar]
  13. Hattori Y., Odagiri H., Nakatani H., Miyagawa K., Naito K., Sakamoto H., Katoh O., Yoshida T., Sugimura T., Terada M. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5983–5987. doi: 10.1073/pnas.87.15.5983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Herman J. G., Graff J. R., Myöhänen S., Nelkin B. D., Baylin S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9821–9826. doi: 10.1073/pnas.93.18.9821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hirono Y., Tsugawa K., Fushida S., Ninomiya I., Yonemura Y., Miyazaki I., Endou Y., Tanaka M., Sasaki T. Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer. Oncology. 1995 May-Jun;52(3):182–188. doi: 10.1159/000227455. [DOI] [PubMed] [Google Scholar]
  16. Horii A., Nakatsuru S., Miyoshi Y., Ichii S., Nagase H., Kato Y., Yanagisawa A., Nakamura Y. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res. 1992 Jun 1;52(11):3231–3233. [PubMed] [Google Scholar]
  17. Imanishi K., Yamaguchi K., Suzuki M., Honda S., Yanaihara N., Abe K. Production of transforming growth factor-alpha in human tumour cell lines. Br J Cancer. 1989 May;59(5):761–765. doi: 10.1038/bjc.1989.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Iwabuchi H., Sakamoto M., Sakunaga H., Ma Y. Y., Carcangiu M. L., Pinkel D., Yang-Feng T. L., Gray J. W. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 1995 Dec 15;55(24):6172–6180. [PubMed] [Google Scholar]
  19. Johns M. M., 3rd, Westra W. H., Califano J. A., Eisele D., Koch W. M., Sidransky D. Allelotype of salivary gland tumors. Cancer Res. 1996 Mar 1;56(5):1151–1154. [PubMed] [Google Scholar]
  20. Kameda T., Yasui W., Yoshida K., Tsujino T., Nakayama H., Ito M., Ito H., Tahara E. Expression of ERBB2 in human gastric carcinomas: relationship between p185ERBB2 expression and the gene amplification. Cancer Res. 1990 Dec 15;50(24):8002–8009. [PubMed] [Google Scholar]
  21. Kuniyasu H., Yasui W., Kitadai Y., Yokozaki H., Ito H., Tahara E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun. 1992 Nov 30;189(1):227–232. doi: 10.1016/0006-291x(92)91548-5. [DOI] [PubMed] [Google Scholar]
  22. Kuniyasu H., Yasui W., Yokozaki H., Akagi M., Akama Y., Kitahara K., Fujii K., Tahara E. Frequent loss of heterozygosity of the long arm of chromosome 7 is closely associated with progression of human gastric carcinomas. Int J Cancer. 1994 Dec 1;59(5):597–600. doi: 10.1002/ijc.2910590504. [DOI] [PubMed] [Google Scholar]
  23. Latil A., Cussenot O., Fournier G., Driouch K., Lidereau R. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res. 1997 Mar 15;57(6):1058–1062. [PubMed] [Google Scholar]
  24. Lee S. W. H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med. 1996 Jul;2(7):776–782. doi: 10.1038/nm0796-776. [DOI] [PubMed] [Google Scholar]
  25. Mayama T., Mori T., Abe K., Sasano H., Nishihira T., Satomi S., Horii A. Analysis of the p53 gene mutations in patients with multiple primary cancers of the oesophagus. Eur J Surg Oncol. 1997 Aug;23(4):298–303. doi: 10.1016/s0748-7983(97)90642-9. [DOI] [PubMed] [Google Scholar]
  26. Mori Y., Shiwaku H., Fukushige S., Wakatsuki S., Sato M., Nukiwa T., Horii A. Alternative splicing of hMSH2 in normal human tissues. Hum Genet. 1997 May;99(5):590–595. doi: 10.1007/s004390050411. [DOI] [PubMed] [Google Scholar]
  27. Nakatani H., Sakamoto H., Yoshida T., Yokota J., Tahara E., Sugimura T., Terada M. Isolation of an amplified DNA sequence in stomach cancer. Jpn J Cancer Res. 1990 Aug;81(8):707–710. doi: 10.1111/j.1349-7006.1990.tb02631.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Nakatsuru S., Yanagisawa A., Ichii S., Tahara E., Kato Y., Nakamura Y., Horii A. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet. 1992 Nov;1(8):559–563. doi: 10.1093/hmg/1.8.559. [DOI] [PubMed] [Google Scholar]
  29. Nishida N., Fukuda Y., Kokuryu H., Sadamoto T., Isowa G., Honda K., Yamaoka Y., Ikenaga M., Imura H., Ishizaki K. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer. 1992 Jul 30;51(6):862–868. doi: 10.1002/ijc.2910510605. [DOI] [PubMed] [Google Scholar]
  30. Nishide T., Emi M., Nakamura Y., Matsubara K. Corrected sequences of cDNAs for human salivary and pancreatic alpha-amylases [corrected]. Gene. 1984 May;28(2):263–270. doi: 10.1016/0378-1119(84)90265-8. [DOI] [PubMed] [Google Scholar]
  31. Ohta M., Inoue H., Cotticelli M. G., Kastury K., Baffa R., Palazzo J., Siprashvili Z., Mori M., McCue P., Druck T. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996 Feb 23;84(4):587–597. doi: 10.1016/s0092-8674(00)81034-x. [DOI] [PubMed] [Google Scholar]
  32. Orita M., Suzuki Y., Sekiya T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 1989 Nov;5(4):874–879. doi: 10.1016/0888-7543(89)90129-8. [DOI] [PubMed] [Google Scholar]
  33. Ouyang H., Shiwaku H. O., Hagiwara H., Miura K., Abe T., Kato Y., Ohtani H., Shiiba K., Souza R. F., Meltzer S. J. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res. 1997 May 15;57(10):1851–1854. [PubMed] [Google Scholar]
  34. Parkin D. M., Lärä E., Muir C. S. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer. 1988 Feb 15;41(2):184–197. doi: 10.1002/ijc.2910410205. [DOI] [PubMed] [Google Scholar]
  35. Ranzani G. N., Renault B., Pellegata N. S., Fattorini P., Magni E., Bacci F., Amadori D. Loss of heterozygosity and K-ras gene mutations in gastric cancer. Hum Genet. 1993 Oct 1;92(3):244–249. doi: 10.1007/BF00244466. [DOI] [PubMed] [Google Scholar]
  36. Sano T., Tsujino T., Yoshida K., Nakayama H., Haruma K., Ito H., Nakamura Y., Kajiyama G., Tahara E. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res. 1991 Jun 1;51(11):2926–2931. [PubMed] [Google Scholar]
  37. Sato M., Mori Y., Sakurada A., Fujimura S., Horii A. A GT dinucleotide repeat polymorphism in intron 1 of the H-cadherin (CDH13) gene. J Hum Genet. 1998;43(4):285–286. doi: 10.1007/s100380050093. [DOI] [PubMed] [Google Scholar]
  38. Sato M., Mori Y., Sakurada A., Fujimura S., Horii A. The H-cadherin (CDH13) gene is inactivated in human lung cancer. Hum Genet. 1998 Jul;103(1):96–101. doi: 10.1007/s004390050790. [DOI] [PubMed] [Google Scholar]
  39. Sato M., Mori Y., Sakurada A., Fukushige S., Ishikawa Y., Tsuchiya E., Saito Y., Nukiwa T., Fujimura S., Horii A. Identification of a 910-kb region of common allelic loss in chromosome bands 16q24.1-q24.2 in human lung cancer. Genes Chromosomes Cancer. 1998 May;22(1):1–8. [PubMed] [Google Scholar]
  40. Sato T., Saito H., Morita R., Koi S., Lee J. H., Nakamura Y. Allelotype of human ovarian cancer. Cancer Res. 1991 Oct 1;51(19):5118–5122. [PubMed] [Google Scholar]
  41. Sato T., Tanigami A., Yamakawa K., Akiyama F., Kasumi F., Sakamoto G., Nakamura Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res. 1990 Nov 15;50(22):7184–7189. [PubMed] [Google Scholar]
  42. Schneider B. G., Pulitzer D. R., Brown R. D., Prihoda T. J., Bostwick D. G., Saldivar V., Rodríguez-Martínez H. A., Gutiérrez-Díaz M. E., O'Connell P. Allelic imbalance in gastric cancer: an affected site on chromosome arm 3p. Genes Chromosomes Cancer. 1995 Aug;13(4):263–271. doi: 10.1002/gcc.2870130406. [DOI] [PubMed] [Google Scholar]
  43. Shiozaki H., Tahara H., Oka H., Miyata M., Kobayashi K., Tamura S., Iihara K., Doki Y., Hirano S., Takeichi M. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol. 1991 Jul;139(1):17–23. [PMC free article] [PubMed] [Google Scholar]
  44. Shurtleff S. A., Meyers S., Hiebert S. W., Raimondi S. C., Head D. R., Willman C. L., Wolman S., Slovak M. L., Carroll A. J., Behm F. Heterogeneity in CBF beta/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood. 1995 Jun 15;85(12):3695–3703. [PubMed] [Google Scholar]
  45. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J Cancer Res Clin Oncol. 1990;116(2):121–131. doi: 10.1007/BF01612665. [DOI] [PubMed] [Google Scholar]
  46. Tamura G., Kihana T., Nomura K., Terada M., Sugimura T., Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 1991 Jun 1;51(11):3056–3058. [PubMed] [Google Scholar]
  47. Tsuda H., Callen D. F., Fukutomi T., Nakamura Y., Hirohashi S. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res. 1994 Jan 15;54(2):513–517. [PubMed] [Google Scholar]
  48. Uchino S., Tsuda H., Noguchi M., Yokota J., Terada M., Saito T., Kobayashi M., Sugimura T., Hirohashi S. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992 Jun 1;52(11):3099–3102. [PubMed] [Google Scholar]
  49. Veronese M. L., Bullrich F., Negrini M., Croce C. M. The t(6;16)(p21;q22) chromosome translocation in the LNCaP prostate carcinoma cell line results in a tpc/hpr fusion gene. Cancer Res. 1996 Feb 15;56(4):728–732. [PubMed] [Google Scholar]
  50. Yokota J., Yamamoto T., Miyajima N., Toyoshima K., Nomura N., Sakamoto H., Yoshida T., Terada M., Sugimura T. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene. 1988 Mar;2(3):283–287. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES